Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was classified as non-ST segment ...
Apr 5, 2022
0
32
A diagnostic tool used by clinicians to predict risk of mortality in heart attack patients is less effective in ethnic minority patients and may result in inappropriate treatments being prescribed, according to new research.
Feb 24, 2022
0
18
Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adverse cardiovascular event as a result of thoracic radiation therapy compared to patients with no coronary artery calcium. ...
Feb 11, 2022
0
19
A study led by Indiana University School of Medicine is challenging standard treatment methods used to prevent muscle damage during heart attack.
Jan 4, 2022
0
15
A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration with ...
Nov 13, 2021
0
13
he primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 trial found that percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet noninferiority ...
Nov 8, 2021
0
2
Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure the severity of artery blockages can lead to significantly improved outcomes after percutaneous coronary intervention (PCI), ...
Nov 4, 2021
0
84
An analysis of healthcare data in Ontario, Canada found a significant decline in referrals and procedures performed for common cardiac interventions after the onset of the COVID-19 pandemic. Patients awaiting coronary bypass ...
Sep 29, 2021
0
2
A study in more than 30,000 heart patients shows that becoming active later in life can be nearly as beneficial to survival as continued activity. The research is presented at ESC Congress 2021.
Aug 24, 2021
0
343
(HealthDay)—Children with multisystem inflammatory syndrome in children (MIS-C) treated with immunomodulators have favorable outcomes at six months, with normalization of left ventricular (LV) systolic function and resolution ...
Aug 9, 2021
0
8
